A detailed history of Northwest & Ethical Investments L.P. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 39,579 shares of TEVA stock, worth $776,935. This represents 0.02% of its overall portfolio holdings.

Number of Shares
39,579
Previous 35,679 10.93%
Holding current value
$776,935
Previous $548 Million 21.15%
% of portfolio
0.02%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

BUY
$12.82 - $18.15 $49,998 - $70,785
3,900 Added 10.93%
39,579 $663 Million
Q1 2025

May 13, 2025

BUY
$14.67 - $22.01 $315,096 - $472,752
21,479 Added 151.26%
35,679 $548 Million
Q4 2024

Feb 11, 2025

BUY
$16.43 - $22.77 $69,006 - $95,634
4,200 Added 42.0%
14,200 $313 Million
Q3 2024

Nov 13, 2024

BUY
$15.81 - $18.96 $82,212 - $98,592
5,200 Added 108.33%
10,000 $180 Million
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $61,344 - $83,520
4,800 New
4,800 $78 Million
Q3 2018

Jul 08, 2025

BUY
$21.06 - $25.65 $2.34 Million - $2.85 Million
110,931 New
110,931 $2.39 Billion
Q2 2017

Jul 08, 2025

SELL
N/A
-13,960 Closed
0 $0
Q1 2017

Jul 08, 2025

SELL
N/A
-41,344 Reduced 74.76%
13,960 $448 Million
Q4 2016

Jul 08, 2025

BUY
N/A
15,340 Added 38.38%
55,304 $2 Billion
Q3 2016

Jul 08, 2025

BUY
N/A
4,285 Added 12.01%
39,964 $1.84 Billion
Q3 2013

Jul 08, 2025

SELL
N/A
-26,709 Closed
0 $0
Q2 2013

Jul 08, 2025

SELL
N/A
-27,738 Reduced 50.94%
26,709 $1.05 Billion
Q1 2013

Jul 08, 2025

BUY
N/A
18,768 Added 52.6%
54,447 $2.16 Billion
Q4 2012

Jul 07, 2025

SELL
N/A
-49,000 Reduced 42.67%
65,835 $2.46 Billion
Q3 2012

Jul 07, 2025

BUY
N/A
14,900 Added 14.91%
114,835 $4.76 Billion
Q2 2012

Jul 07, 2025

BUY
N/A
2,400 Added 2.46%
99,935 $3.94 Billion
Q1 2012

Jul 07, 2025

SELL
N/A
-38,600 Reduced 28.35%
97,535 $4.39 Billion
Q4 2011

Jul 07, 2025

BUY
N/A
9,206 Added 7.25%
136,135 $5.49 Billion
Q3 2011

Jul 07, 2025

BUY
N/A
32,106 Added 33.86%
126,929 $4.72 Billion
Q2 2011

Jul 07, 2025

SELL
N/A
-4,000 Reduced 4.05%
94,823 $4.57 Billion
Q1 2011

Jul 07, 2025

BUY
N/A
63,144 Added 176.98%
98,823 $4.96 Billion
Q4 2010

Jul 03, 2025

SELL
N/A
-16,877 Reduced 11.58%
128,823 $6.72 Billion
Q3 2010

Jul 03, 2025

BUY
N/A
27,676 Added 23.45%
145,700 $7.69 Billion
Q2 2010

Jul 03, 2025

SELL
N/A
-19,677 Reduced 14.29%
118,024 $6.14 Billion
Q1 2010

Jul 03, 2025

BUY
N/A
48,061 Added 53.62%
137,701 $8.69 Billion
Q4 2009

Jul 03, 2025

SELL
N/A
-86,867 Reduced 49.21%
89,640 $5.04 Billion
Q3 2009

Jul 03, 2025

BUY
N/A
140,828
176,507 $8.92 Billion

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $21.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Northwest & Ethical Investments L.P. Portfolio

Follow Northwest & Ethical Investments L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest & Ethical Investments L.P., based on Form 13F filings with the SEC.

News

Stay updated on Northwest & Ethical Investments L.P. with notifications on news.